Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly

Hofseth Biocare ASA

13/02/2026 07:38

Feb 13 (Reuters) - Hofseth Biocare ASA HBC.OL:

HOFSETH BIOCARE Q4 REVENUE NOK 72.2 MILLION

HOFSETH BIOCARE Q4 EBITDA NOK -26.5 MILLION

HOFSETH BIOCARE ASA - Q4 NET CASH FLOW NOK 1.57 MILLION

DEMAND OUTLOOK FOR 2026 IS IMPROVING RAPIDLY

Q4 PROFIT NOK -48.3 MILLION

Q4 EPS NOK -0.12

Source text: ID:nGNEBBcFl

Further company coverage: HBC.OL

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))